-
1 Comment
Global Cord Blood Corporation is currently in a long term uptrend where the price is trading 17.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.
Global Cord Blood Corporation's total revenue sank by 13.1% to $291M since the same quarter in the previous year.
Its net income has dropped by 19.6% to $117M since the same quarter in the previous year.
Based on the above factors, Global Cord Blood Corporation gets an overall score of 2/5.
| Industry | |
|---|---|
| ISIN | None |
| Exchange | F |
| CurrencyCode | EUR |
| Sector |
| Dividend Yield | 0.0% |
|---|---|
| Market Cap | 491M |
| PE Ratio | 6.28 |
| Target Price | None |
| Beta | -0.27 |
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2021, it operated three cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6CB.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
